跳至主要内容
临床试验/NCT00900029
NCT00900029已完成不适用

A Twenty-Four Week Non-Interventional Safety Follow-Up to HP 802-247-09-015

Healthpoint30 个研究点 分布在 2 个国家目标入组 206 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Healthpoint
入组人数
206
试验地点
30
主要终点
The Number of Participants With Closed Target Ulcers at Each Visit

研究概览

简要总结

This is a 24-week observational follow safety study for Study 802-247-09-015.

详细描述

The objective of this study is to examine the durability of previous target wound closures, identify new test article-related adverse events, record new target wound closures, and examine ongoing adverse events not resolved in subjects who participated in HP 802-247-09-015.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

The Number of Participants With Closed Target Ulcers at Each Visit

时间窗: Over the 24-week study period, at each of the bi-monthly visits

At each visit the status of closed target ulcers was evaluated as remained closed or re-opened.

Number of Subjects With Target Wound Closed for the First Time During the Study Period.

时间窗: Over the 24-week study period, at each of the bi-monthly visits

At each visit the status of open target ulcers was evaluated as "remained open" or "closed".

次要结局

未报告次要终点

研究者

发起方
Healthpoint
申办方类型
Industry
责任方
Sponsor

研究点 (30)

Loading locations...

相似试验

Unknown
不适用
Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg UlcerVenous Leg Ulcer
NCT01658618Healthpoint440
已完成
不适用
Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247Venous Leg Ulcer (VLU)
NCT01970657Healthpoint221
进行中(未招募)
1 期
Study of the safety and effectiveness of investigational study drug EVP-6124 in subjects with Alzheimer's DiseaseAlzheimer’s DiseaseMedDRA version: 17.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disordersMedDRA version: 17.0 Level: SOC Classification code 10029205 Term: Nervous system disorders System Organ Class: 10029205 - Nervous system disorders
EUCTR2013-002654-75-GBForum Pharmaceuticals Inc.348
进行中(未招募)
1 期
Study of the safety and effectiveness of investigational studydrug EVP-6124 in subjects with Alzheimer's Disease
EUCTR2013-002654-75-DEForum Pharmaceuticals Inc.1,300
进行中(未招募)
不适用
Study of the safety and effectiveness of investigational studydrug EVP-6124 in subjects with Alzheimer's DiseaseAlzheimer’s DiseaseMedDRA version: 17.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 17.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2013-002654-75-ITForum Pharmaceuticals Inc.1,580